Business model for sustainable growth

BioGaia has two types of distribution – via our distribution partners and direct distribution. The majority of BioGaia’s revenue comes from gut health products, such as chewable tablets, drops for children with colic, and oral health products. Revenue is also earned from the sale of bacterial cultures to be used in licensees’ products (such as infant formula and dairy products), as well as royalties for the use of L. reuteri in licensees’ products. BioGaia’s products are available in more than 100 markets through sales via nutrition and pharmaceutical companies and our own subsidiaries.